Important Safety Information Prescribing Information Patient Prescribing Information Print This Page
Sign up for updates

Doctor Discussion Guide

It can be difficult—even stressful—to talk to a healthcare provider about erectile dysfunction (ED). But you can be sure that you are not the first man in the world to have this problem. Millions of men live with ED every day. Often, ED is caused by other medical conditions, so it’s very important to talk about it. It’s also important to know that ED is treatable.

Getting the conversation started

You should do whatever makes you most comfortable. But if you need help talking about ED with your healthcare professional, try these trusted tips:

Share your answers from our "Do You Have ED?" section with your healthcare provider.

Or use these icebreakers:

  • "I don't know what's wrong, but I haven't been able to perform in bed even though I'm taking the pills to help.”
  • "I heard having high blood pressure can cause erection problems. Can that happen to me?"
  • "I know I have diabetes. Can it affect my sexual performance?"
  • "Could medicines I take cause me to have erection problems?"

Exam-room reminder

At your visit, remind your healthcare provider about any medication you are taking. Include over-the-counter medicine that you use. Tell your healthcare provider about any vitamins and supplements you take, as well.

Most of all, take time to talk to your healthcare provider about your condition. It's the best way for you to get the help you need.



CAVERJECT is used to treat erectile dysfunction (ED) due to neurogenic, vasculogenic, psychogenic, or mixed etiology.


Important Safety Information

CAVERJECT should not be used in men hypersensitive to alprostadil, men with conditions that may predispose them to priapism (such as sickle cell anemia or trait, multiple myeloma or leukemia), men with anatomical deformities of the penis (such as angulation, cavernosal fibrosis or Peyronie’s disease), men with penile implants, or men for whom sexual activity is inadvisable or is contraindicated.

CAVERJECT should not be used in women, children or newborns.

Patients should be instructed to immediately report to his physician any erection lasting 4 hours or longer. If unavailable, patient must seek immediate medical assistance.

CAVERJECT can cause penile fibrosis or Peyronie’s disease.

Use of Caverject in patients who take anticoagulants, such as warfarin or heparin, should be with precaution as they may have increased tendency for bleeding after Caverject injections.

The most common side effect of CAVERJECT® (alprostadil for injection) was penile pain, reported by 37% of patients in clinical studies. Other side effects were prolonged erection, penile fibrosis and injection site hematoma. To lower the risk of prolonged erections or priapism, Caverject should be titrated slowly to the lowest effective dose.

For Full Prescribing and Patient Information for CAVERJECT®, please click here.